$9.16
-0.4-4.23%
At Close: -
$9.16
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
EyePoint Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of EyePoint Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
EYPT | EyePoint Pharmaceuticals | -$0.57 | -$0.52 | — | — | $9.11M | $9.59M | — | — | 08/05/2024 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$0.56 | -$0.42 | -$0.55 | -30.95% | $7.68M | $9.92M | $11.68M | 17.78% | 05/08/2024 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$1.16 | -$0.49 | -$0.33 | 32.65% | $10.53M | $8.90M | $14.03M | 57.62% | 03/07/2024 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$0.49 | -$0.51 | -$0.33 | 35.29% | $10.01M | $7.52M | $15.20M | 102.15% | 11/01/2023 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$0.52 | $0.41 | -$0.57 | -239.02% | $11.56M | $79.03M | $9.11M | -88.48% | 08/02/2023 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$0.56 | -$0.68 | -$0.56 | 17.65% | $9.29M | $7.43M | $7.68M | 3.41% | 05/03/2023 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$0.59 | -$0.61 | -$0.61 | 0.00% | $11.54M | $10.40M | $10.53M | 1.28% | 03/02/2023 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$0.58 | -$0.70 | -$0.49 | 30.00% | $9.06M | $10.64M | $10.01M | -5.90% | 11/02/2022 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$0.42 | -$0.52 | -$0.52 | 0.00% | $9.01M | $10.87M | $11.56M | 6.39% | 08/03/2022 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$0.50 | -$0.58 | -$0.56 | 3.45% | $7.32M | $9.89M | $9.29M | -6.03% | 05/04/2022 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$0.10 | -$0.53 | -$0.59 | -11.32% | $4.12M | $9.80M | $11.54M | 17.80% | 03/03/2022 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$0.30 | -$0.40 | -$0.58 | -45.00% | $7.49M | $9.84M | $9.06M | -7.94% | 11/03/2021 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$1.00 | -$0.43 | -$0.42 | 2.33% | $8.63M | $9.13M | $9.01M | -1.28% | 08/04/2021 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$1.10 | -$0.46 | -$0.50 | -8.70% | $2.51M | $7.93M | $7.32M | -7.65% | 05/05/2021 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$1.00 | -$0.17 | -$1.00 | -488.24% | $7.21M | $20.44M | $7.13M | -65.11% | 03/04/2021 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$1.50 | -$0.50 | -$0.30 | 40.00% | $2.01M | $10.54M | $15.70M | 48.91% | 11/05/2020 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$1.10 | -$1.00 | -$1.00 | 0.00% | $742.00K | $3.73M | $4.12M | 10.51% | 08/05/2020 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$2.00 | -$1.00 | -$1.10 | -10.00% | $486.00K | $7.25M | $7.49M | 3.30% | 05/06/2020 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$6.20 | -$1.10 | -$1.00 | 9.09% | $715.00K | $7.80M | $8.63M | 10.68% | 03/05/2020 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$1.50 | -$1.40 | -$1.50 | -7.14% | $928.00K | $5.02M | $2.51M | -50.02% | 11/07/2019 | Get Alert |
EYPT | EyePoint Pharmaceuticals | -$1.30 | -$1.10 | -$1.10 | 0.00% | $933.00K | $6.69M | $7.21M | 7.77% | 08/07/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $-0.55 | $-0.42 | -30.9 % |
Dec 2023 | 2024-03-07 | $-0.33 | $-0.49 | 32.6 % |
Sep 2023 | 2023-11-01 | $-0.33 | $-0.51 | 35.3 % |
Jun 2023 | 2023-08-02 | $-0.57 | $0.41 | -239.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $11.68M | $9.92M | 17.8 % |
Dec 2023 | 2024-03-07 | $14.03M | $8.90M | 57.6 % |
Sep 2023 | 2023-11-01 | $15.20M | $7.52M | 102.2 % |
Jun 2023 | 2023-08-02 | $9.11M | $79.03M | -88.5 % |
EyePoint Pharmaceuticals (EYPT) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
The Actual EPS was $-0.55, which missed the estimate of $-0.42.
The Actual Revenue was $11.7M, which beat the estimate of $9.9M.
Browse earnings estimates, EPS, and revenue on all stocks.